Group 1 - Bayer Group announced a restructuring of its crop science division to enhance global competitiveness, including the cessation of production at the Frankfurt plant by the end of 2028 [1] - The restructuring is a response to significant overcapacity and price competition from Asian generic manufacturers, aiming to maintain production facilities in Germany while offering competitive products [1][2] - The Frankfurt plant primarily produces active ingredients and formulations for herbicides, with plans to divest some production activities and transfer remaining operations to the Dormagen and Knapsack plants [1][2] Group 2 - Bayer stated that not all of the approximately 500 employees at the Frankfurt plant will lose their jobs, as some positions will be transferred due to the planned sale of certain business segments [2] - The Dormagen plant, which employs nearly 1,200 people, will see around 200 positions affected, but it will remain Bayer's largest production base for active ingredients and crop protection products [2] - Bayer's restructuring is part of a comprehensive "five-year framework" initiated in March to address challenges in the crop science division and ensure global competitiveness [2] Group 3 - In Q1, Bayer's crop science division reported a 3.3% decline in sales to €7.58 billion, with adjusted EBITDA down 10.2% to €2.557 billion [2] - The company plans to focus on strategic innovative technologies and products, emphasizing the importance of innovation in active ingredients for crop protection [2] - Bayer aims to launch several significant products from its crop science R&D activities over the next decade [2]